$ 194.33
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, o
Target Price
The average target price of DHR is 239 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
